SE9002212D0 - Igg binding protein - Google Patents

Igg binding protein

Info

Publication number
SE9002212D0
SE9002212D0 SE9002212A SE9002212A SE9002212D0 SE 9002212 D0 SE9002212 D0 SE 9002212D0 SE 9002212 A SE9002212 A SE 9002212A SE 9002212 A SE9002212 A SE 9002212A SE 9002212 D0 SE9002212 D0 SE 9002212D0
Authority
SE
Sweden
Prior art keywords
proteins
igg
protein
binding protein
igg binding
Prior art date
Application number
SE9002212A
Other languages
English (en)
Inventor
K-H Schmidt
Original Assignee
Hightech Receptor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hightech Receptor Ab filed Critical Hightech Receptor Ab
Priority to SE9002212A priority Critical patent/SE9002212D0/sv
Publication of SE9002212D0 publication Critical patent/SE9002212D0/sv
Priority to JP3511704A priority patent/JP3040817B2/ja
Priority to PCT/SE1991/000447 priority patent/WO1991019740A1/en
Priority to DE69101008T priority patent/DE69101008T2/de
Priority to EP91912563A priority patent/EP0529003B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SE9002212A 1990-06-21 1990-06-21 Igg binding protein SE9002212D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9002212A SE9002212D0 (sv) 1990-06-21 1990-06-21 Igg binding protein
JP3511704A JP3040817B2 (ja) 1990-06-21 1991-06-20 ＩｇＧ結合タンパク質
PCT/SE1991/000447 WO1991019740A1 (en) 1990-06-21 1991-06-20 IgG-BINDING PROTEIN
DE69101008T DE69101008T2 (de) 1990-06-21 1991-06-20 Ig-g bindendes protein.
EP91912563A EP0529003B1 (en) 1990-06-21 1991-06-20 IgG-BINDING PROTEIN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002212A SE9002212D0 (sv) 1990-06-21 1990-06-21 Igg binding protein

Publications (1)

Publication Number Publication Date
SE9002212D0 true SE9002212D0 (sv) 1990-06-21

Family

ID=20379837

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9002212A SE9002212D0 (sv) 1990-06-21 1990-06-21 Igg binding protein

Country Status (5)

Country Link
EP (1) EP0529003B1 (sv)
JP (1) JP3040817B2 (sv)
DE (1) DE69101008T2 (sv)
SE (1) SE9002212D0 (sv)
WO (1) WO1991019740A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9201331D0 (sv) * 1992-04-28 1992-04-28 Hightech Receptor C O Active Protein l och hybridproteiner daerav
SE9503495L (sv) 1995-10-09 1997-04-10 Actinova Ltd Nytt protein
US6043069A (en) * 1996-03-26 2000-03-28 Amrad Operations Pty. Ltd. Catalytic antibodies and a method of producing same
AUPO930697A0 (en) * 1997-09-19 1997-10-09 Walter And Eliza Hall Institute Of Medical Research, The Catalytic antibodies and a method of producing same
GB9723825D0 (en) * 1997-11-11 1998-01-07 Actinova Ltd Nuclear targeting by means of bacterial proteins
GB9723824D0 (en) 1997-11-11 1998-01-07 Actinova Ltd Cytostatic agents
GB9807890D0 (en) * 1998-04-09 1998-06-10 Actinova Ltd Peptides
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US8323908B2 (en) 2007-09-14 2012-12-04 Genovis Ab Method of assessing glycosylation state or functional quality of an IgG containing sample
BRPI0921286B8 (pt) 2008-11-05 2022-10-25 Wyeth Llc Composição imunogênica com múltiplos componentes para a prevenção de doença por estreptococos beta-hemolíticos (bhs).

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE451596B (sv) * 1983-06-22 1987-10-19 Excorim Kb Forfarande for utvinning av protein g
JP2871709B2 (ja) * 1988-11-21 1999-03-17 住友製薬株式会社 免疫グロブリンｇ結合活性を有する新規な蛋白質プロテインｈ、該蛋白質をコードする遺伝子及び該蛋白質の製造法

Also Published As

Publication number Publication date
EP0529003B1 (en) 1994-01-12
DE69101008D1 (de) 1994-02-24
DE69101008T2 (de) 1994-07-28
WO1991019740A1 (en) 1991-12-26
JPH06503706A (ja) 1994-04-28
JP3040817B2 (ja) 2000-05-15
EP0529003A1 (en) 1993-03-03

Similar Documents

Publication Publication Date Title
DK43890A (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
GR3030811T3 (en) Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
NZ227177A (en) Vectors and dna compounds for the expression of human protein c
ATE132197T1 (de) Monoklonale antikörper
EP0909814A3 (en) Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
NZ224057A (en) A polypeptide of a vascular anticoagulant protein and method of preparation
SE9002212D0 (sv) Igg binding protein
ATE165363T1 (de) Verfahren und mittel zur sortierung und bestimmung biologischer informationen
PT84089A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
DE3887750T2 (de) Selektive entfernung von immunkomplexen.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
IL130164A0 (en) Mammalian chemokines
DE69736158D1 (de) Glutamine: Fructose-6-Phosphat Amidotransferase (GFAT), ihre Herstellung und Verwendung
NZ333408A (en) Methods for determining the presence of brain protein s-100
DE3882411T2 (de) Verfahren zur Trennung von aktiviertem menschlichem Protein C.
AU4981093A (en) Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof
DK0592600T3 (da) Protein S polypeptider og anvendelse deraf
EP0780472A3 (en) Stress proteins
PT88913A (pt) Processo para a preparacao da proteina pp4-x anticoagulante
SE9002213D0 (sv) Albumin binding proteins
NO882836D0 (no) Fremgangsmaate for kjemisk modifisering av protider (proteiner og peptider).
AU2713288A (en) Human-type serum obtained from fractions resulting from the fractionation of human blood or serum, process for its preparation and laboratory reaction containing said serum
IT8748142A0 (it) Metodo diagnostico basato sull'impiego di anticorpi ed antigeni specificatamente adatti a rivelare i processi di denaturazione proteica e la conseguente reazione autoimmunitaria che stanno alla base di alcune malattie autoimmunitarie
Marusic Purification of specific DNA binding proteins from human cells
DE3888078D1 (de) Veränderungsverfahren für Peptide und Proteine.